Device Trial Radar · NCT06897319
High-Flow Tracheal Therapy on Tracheobronchial Secretions in Tracheostomized Patients
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
Jan 1, 2027
Primary completion
Jan 1, 2028
Study completion Aug 1, 2028
Sponsor
- Lead sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de LouvainAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 26, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (outcomes assessor)
- Primary purpose
- Supportive care
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This monocentric, randomized crossover study aims to assess the impact of high-flow tracheal therapy (HFT) on the rheological properties of tracheobronchopulmonary secretions in tracheostomized patients. The primary objective is to compare the viscoelastic characteristics of secretions collected with and without HFT. Secondary objectives include evaluating the effects of HFT on dyspnea, patient comfort, and secretion appearance. The study will take place at Cliniques Universitaires Saint-Luc, with adult tracheostomized patients undergoing standard care.
Conditions
- Tracheostomized Patients
Interventions
High-Flow Tracheal TherapyDevice
Device: Airvo 2 (Fisher \& Paykel Healthcare) Settings: Flow rate start at 40L/min and will be adapted according to tolerance; temperature aimed at 37°C or 34°C according to tolerance, FiO₂ set (if needed) according to SpO2 target values.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Critical stress (σc)Time frame: Measured three times: at baseline, after one hour, after 4 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Cliniques universitaires Saint-Luc
Brussels, Brussels Capital, Belgium
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.